Clinical Trial Update: An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dexamethasone at different doses for managing immune thrombocytopenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia | Phase 2 | Status: COMPLETED